These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10601072)

  • 1. Severe OHSS: An 'epidemic' of severe OHSS: a price we have to pay?
    Graf MA; Fischer R
    Hum Reprod; 1999 Dec; 14(12):2930-1. PubMed ID: 10601072
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe OHSS: An 'epidemic' caused by doctors.
    Roest J
    Hum Reprod; 1999 Sep; 14(9):2183. PubMed ID: 10471253
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe OHSS-an acceptable price?
    Forman RG
    Hum Reprod; 1999 Nov; 14(11):2687-8. PubMed ID: 10548601
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe OHSS: An 'epidemic' of severe OHSS: a price we have to pay?
    Abramov Y; Elchalal U; Schenker JG
    Hum Reprod; 1999 Sep; 14(9):2181-3. PubMed ID: 10469676
    [No Abstract]   [Full Text] [Related]  

  • 5. An eight year review of hospitalization for ovarian hyperstimulation syndrome.
    Qasim SM; Karacan M; Kemmann E
    Clin Exp Obstet Gynecol; 1997; 24(2):49-52. PubMed ID: 9342460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe OHSS: decreasing the risk of severe ovarian hyperstimulation syndrome.
    Al-Ramahi M
    Hum Reprod; 1999 Oct; 14(10):2421-2. PubMed ID: 10527959
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization.
    Aramwit P; Pruksananonda K; Kasettratat N; Jammeechai K
    Am J Health Syst Pharm; 2008 Jun; 65(12):1148-53. PubMed ID: 18541685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medically assisted conceptions. Ovarian complications].
    Izard V
    Soins Gynecol Obstet Pueric Pediatr; 1991 Nov; (126):25-7. PubMed ID: 1962268
    [No Abstract]   [Full Text] [Related]  

  • 9. Unpredictable cases of complicated ovarian hyperstimulation in IVF.
    Delvigne A; Vandromme J; Demeestere I; Leroy F
    Int J Fertil Womens Med; 1997; 42(4):268-70. PubMed ID: 9309462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hyperstimulation syndrome and thrombotic events.
    Mor YS; Schenker JG
    Am J Reprod Immunol; 2014 Dec; 72(6):541-8. PubMed ID: 25146913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A child at all costs? At what price? Consequences for the mother].
    Belaisch-Allart J; Mayenga JM
    Contracept Fertil Sex; 1997 Apr; 25(4):279-84. PubMed ID: 9229517
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ovarian hyperstimulation syndrome after stimulation with highly purified hMGfor in vitro fertilization: Observational study SHOview].
    Barrière P; Dewailly D; Duhamel A; Gayet V
    Gynecol Obstet Fertil Senol; 2017 May; 45(5):283-290. PubMed ID: 28461237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.
    Humaidan P; Nelson SM; Devroey P; Coddington CC; Schwartz LB; Gordon K; Frattarelli JL; Tarlatzis BC; Fatemi HM; Lutjen P; Stegmann BJ
    Hum Reprod; 2016 Sep; 31(9):1997-2004. PubMed ID: 27343272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe OHSS: patients should be allowed to weigh the morbidity of OHSS against the benefits of parenthood.
    Mathur RS; Jenkins JM
    Hum Reprod; 1999 Sep; 14(9):2183-5. PubMed ID: 10469677
    [No Abstract]   [Full Text] [Related]  

  • 16. Complications of assisted conception techniques.
    Davis OK
    Curr Opin Obstet Gynecol; 1990 Oct; 2(5):721-5. PubMed ID: 2130974
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
    Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
    Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome (OHSS): ovarian mutilating surgery is not an option in the management of severe OHSS.
    Bellver J; Escudero E; Pellicer A
    Hum Reprod; 2003 Jul; 18(7):1363-7. PubMed ID: 12832357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.